Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Scott M Dinehart"'
Autor:
Guilherme Rabinowits, Michael R. Migden, Todd E. Schlesinger, Robert L. Ferris, Morganna Freeman, Valerie Guild, Shlomo Koyfman, Anna C. Pavlick, Neil Swanson, Gregory T. Wolf, Scott M. Dinehart
Publikováno v:
JID Innovations, Vol 1, Iss 4, Pp 100045- (2021)
Cutaneous squamous cell carcinoma is the second most common skin cancer in the United States. Currently, there is no standardized management approach for patients with cutaneous squamous cell carcinoma who develop metastatic or locally advanced disea
Externí odkaz:
https://doaj.org/article/7bfa396119cd430f85368f3066722ea1
Autor:
Leah M Douglas, Robert W. Cook, Sarah J. Kurley, Aaron S. Farberg, Scott M Dinehart, Kyle R. Covington, Mary A Hall
Publikováno v:
Current Medical Research and Opinion. 36:1301-1307
Objective: To integrate gene expression profiling into the management of high-risk cutaneous squamous cell carcinoma (cSCC) within the National Comprehensive Cancer Network (NCCN) guidelines to improve risk-aligned management recommendations.Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3b9e96a759a5cdced7056249a6900b5
https://doi.org/10.1080/03007995.2020.1763284
https://doi.org/10.1080/03007995.2020.1763284
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 4:279-283
Objectives: Prurigo nodularis (PN) is a disease of aberrant and recalcitrant itching which is difficult to effectively manage. There are no current FDA-approved therapies for PN. The current topical and systemic medications used for this condition pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cb2a37a4e3cb5eb7f7285d0cfe3cf50
https://doi.org/10.25251/skin.4.3.13
https://doi.org/10.25251/skin.4.3.13
Publikováno v:
Journal of the American Academy of Dermatology. 88:e19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34052476bddaf1e339ec12fb15babb09
https://doi.org/10.1016/j.jaad.2018.07.069
https://doi.org/10.1016/j.jaad.2018.07.069
Publikováno v:
American Journal of Clinical Dermatology
Background The advent of molecular medicine may allow for individualized cancer prognostication, which should enable better clinical management and, hopefully, improve patient outcomes. A 31-gene expression profile (31-GEP) test is currently availabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e5f79cbbd6150a2b9372b4ef1ad6aa
http://europepmc.org/articles/PMC6872504
http://europepmc.org/articles/PMC6872504
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 2:90-95
Vismodegib is an oral, small-molecule hedgehog pathway inhibitor (HHI) approved for the treatment of locally advanced and metastatic basal cell carcinoma. While an effective treatment option for these conditions, HHI therapy is associated with muscle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::275753f4cef0db45b77e07fa62734934
https://doi.org/10.25251/skin.2.2.1
https://doi.org/10.25251/skin.2.2.1
Autor:
Morganna Freeman, Guilherme Rabinowits, Shlomo A. Koyfman, Robert L. Ferris, Anna C. Pavlick, Todd E. Schlesinger, Scott M. Dinehart, Neil A. Swanson, Valerie Guild, Gregory T. Wolf, Michael R. Migden
Publikováno v:
JID Innovations
JID Innovations, Vol 1, Iss 4, Pp 100045-(2021)
JID Innovations, Vol 1, Iss 4, Pp 100045-(2021)
Cutaneous squamous cell carcinoma is the second most common skin cancer in the United States. Currently, there is no standardized management approach for patients with cutaneous squamous cell carcinoma who develop metastatic or locally advanced disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a03b4c9b5149f85617e4f95aeefa47ab
https://doi.org/10.1016/j.xjidi.2021.100045
https://doi.org/10.1016/j.xjidi.2021.100045
Publikováno v:
Journal of cutaneous pathologyREFERENCES. 47(5)
Background The use of immunohistochemical (IHC) stains in dermatopathology is commonplace; however, little is known regarding utilization trends in melanoma diagnosis. Current Medicare local coverage determinations (LCDs) state that most pigmented le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e33a03470a763e681c1fdb28fecbece
https://pubmed.ncbi.nlm.nih.gov/31955450
https://pubmed.ncbi.nlm.nih.gov/31955450
Autor:
Robert L. Ferris, Shlomo A. Koyfman, Anna C. Pavlick, Scott M. Dinehart, Neil A. Swanson, Michael R. Migden, Morganna Freeman, Guilherme Rabinowits, Todd E. Schlesinger, Gregory T. Wolf, Valerie Guild, Chrysalyne D. Schmults
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 3:S50
not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69752a4225b96201dc3877f137016018
https://doi.org/10.25251/skin.3.supp.50
https://doi.org/10.25251/skin.3.supp.50
Autor:
Eric S. Armbrecht, Scott M. Dinehart, Brent R. Moody, Scott W. Fosko, Ali Hendi, George J. Hruza, Brett M. Coldiron, Howard W. Rogers, Michel A. McDonald, John G. Albertini
Publikováno v:
Journal of Investigative Dermatology. 134(4):1133-1135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a87ca66e5259e890124228a431376b78